A detailed history of Brueske Advisory Services, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Brueske Advisory Services, LLC holds 1,873 shares of JNJ stock, worth $373,813. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,873
Previous 1,780 5.22%
Holding current value
$373,813
Previous $272 Million 27.73%
% of portfolio
0.19%
Previous 0.18%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$155.17 - $185.42 $14,430 - $17,244
93 Added 5.22%
1,873 $347 Million
Q2 2025

Jul 18, 2025

SELL
$146.36 - $159.82 $2,634 - $2,876
-18 Reduced 1.0%
1,780 $272 Million
Q1 2025

Apr 22, 2025

BUY
$142.06 - $167.7 $8,665 - $10,229
61 Added 3.51%
1,798 $298 Million
Q4 2024

Feb 05, 2025

BUY
$143.34 - $165.86 $248,981 - $288,098
1,737 New
1,737 $251 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Brueske Advisory Services, LLC Portfolio

Follow Brueske Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brueske Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brueske Advisory Services, LLC with notifications on news.